Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06302595 · ClinicalTrials.gov registry record · NA
MRI Guided Prostate Biopsy
A NA study of Suspected Prostate Cancer, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06302595 is a NA study of Suspected Prostate Cancer that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06302595, a NA study of Suspected Prostate Cancer, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the feasibility of magnetic resonance (MR) guided prostate biopsy using a needle holder frame. This frame is used to help position the needle used for the biopsy. The feasibility in this study is defined as whether the needle holder frame enables accurate tissue sampling from a suspicious region in the prostate found on an MR image. If it does, a biopsy can be carried out with the needle holder frame safely in a clinical routine. The study will be conducted during a routine MR-guided prostate biopsy procedure with an investigational needle holder frame instead of a conventional needle-guiding template.
Conditions Studied
Interventions
- DEVICE MRI-guided prostate biopsy using the needle holder frame.
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-08-24 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06302595
The ClinicalTrials.gov registry entry for NCT06302595 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suspected Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI-guided prostate biopsy using the needle holder frame. is the first listed.
NCT06302595 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06302595 about?
NCT06302595 is a clinical study titled "MRI Guided Prostate Biopsy". This study aims to assess the feasibility of magnetic resonance (MR) guided prostate biopsy using a needle holder frame. This frame is used to help position the needle used for the biopsy. The feasibility in this study is defined as whether the needle holder frame enables accurate tissue sampling fr...
What is the current status of trial NCT06302595?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-08-24. Estimated completion is 2026-06.
What conditions does trial NCT06302595 study?
This clinical trial studies the following conditions: Suspected Prostate Cancer.
What interventions are being tested in trial NCT06302595?
The interventions under investigation include: MRI-guided prostate biopsy using the needle holder frame. (DEVICE).
Who is sponsoring clinical trial NCT06302595?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06302595 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.